Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly Asia Ventures.

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...

Valo Health is eligible for a further $1.9 billion in potential milestone payments for up to nine new drug programs "Novo Nordisk, Valo Health Expand Drug Discovery and Development Pact -- Update," at ...

Stada has lined up a new independent chairman and board of directors in a key step for the private equity-backed German drug ...

Stada has lined up a new independent chairman and board of directors in a key step for the private equity-backed German drug ...

Britain's Terry Smith made public for the first time why Fundsmith Equity Fund dumped its Diageo stake last year.